Stephan Kirschbaum
Corporate Officer/Principal bij DOTTIKON ES HOLDING AG
Vermogen: 1 M $ op 31-03-2024
Profiel
Stephan Kirschbaum is currently the Chairman & Chief Executive Officer at Dottikon Es America, Inc. He is also the Head of Business Development at Dottikon ES Holding AG and a Member of the Management Board at Dottikon Exclusive Synthesis AG.
Previously, he worked as the Head of Strategic Projects & Business Management at UBS AG from 2005 to 2009.
Prior to that, he was an Engagement Manager at McKinsey & Co., Inc. (Germany) from 1999 to 2005.
He also worked as a Research Scientist at the University of California, Santa Barbara from 1997 to 1999.
Dr. Kirschbaum holds a doctorate degree from the University of Karlsruhe.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
DOTTIKON ES HOLDING AG
0.03% | 31-03-2023 | 3 934 ( 0.03% ) | 1 M $ | 31-03-2024 |
Actieve functies van Stephan Kirschbaum
| Bedrijven | Functie | Begin |
|---|---|---|
| DOTTIKON ES HOLDING AG | Corporate Officer/Principal | 01-01-2009 |
| Dottikon Es America, Inc. | Chief Executive Officer | - |
Dottikon Exclusive Synthesis AG
 Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Corporate Officer/Principal | - |
Eerdere bekende functies van Stephan Kirschbaum
| Bedrijven | Functie | Einde |
|---|---|---|
| UBS | Corporate Officer/Principal | 01-01-2009 |
| Mckinsey & Co., Inc. (Germany) | Corporate Officer/Principal | 01-01-2005 |
| University of California, Santa Barbara | Chief Tech/Sci/R&D Officer | 01-01-1999 |
Opleiding van Stephan Kirschbaum
| University of Karlsruhe | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DOTTIKON ES HOLDING AG | Process Industries |
| Bedrijven in privébezit | 4 |
|---|---|
UBS AG
 UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Health Technology |
| Dottikon Es America, Inc. | |
| Mckinsey & Co., Inc. (Germany) |
